Healthcare and Biotechnology: Advancells and MRIIRS announce research partnership

Advancells, MRIIRS sign agreement to promote research in Healthcare and Biotechnology

Advancells, MRIIRS sign agreement to promote research in Healthcare and Biotechnology

The partnership between Advancells and MRIIRS will benefit students, researchers and the wider community in strengthening the research in Healthcare and Biotechnology area for betterment of mankind.

Advancells, the Human Stem Cells research firm and Manav Rachna International Institute of Research and Studies (MRIIRS), Faridabad signed a research partnership and an exclusive license agreement to promote industry-academia exchange between the two entities, apparently to benefit students, researchers and the wider community in strengthening the research in Healthcare and Biotechnology area for betterment of mankind. The alliance will also be instrumental in deepening the market insights for stem cell therapy, with focus on optimizing deliverables from channel members.

Stating that Advancells Group believed in encouraging and empowering the students at MRIIRS by sharing their experiences and knowledge in the field of Stem Cell Technology, in exchange of which the fhe firm would also get an opportunity to receive education for the several courses and study programmes at the University, Vipul Jain, CEO of Advancells said: “We are aiming at organising joint international conferences, symposia, and workshops for our participants and developing other mutually beneficial programs like skill-oriented certificate courses in Stem Cell Technology for both the parties in due course of time.”

Advancells, MRIIRS sign agreement to promote research in Healthcare and Biotechnology arenas

While elaborating on the occasion, Dr. Sarita Sachdeva, Dean Research, MRIIRS, pointed out: “We are pleased to collaborate with Advancells, for coming together to undertake meaningful research and hope to utilise each other’s expertise with the stem cells pathway to identify promising results that could one day become breakthroughs in healthcare industry.”

To give an over view of Advancells Group, it is a diversified research oriented entity dealing in development of therapeutic usage of Human Stem Cells, Primary Cells and other biological material used in translational medicine supporting research and development in Drug Discovery platforms and various other research based applications. Advancells is leading the field of stem cell therapies in India and abroad, with representative offices in Bangladesh and Australia. The company provides arrangements for stem cell banking and protocols for partner doctors and hospitals which they can use for treating the patients using regenerative medicine.

The Manav Rachna International Institute of Research and Studies is a Deemed-to-be-University under section 3 of the UGC Act, 1956, and a NAAC accredited ‘A’ Grade Institution. It is a continuum of excellence from the Career Institute of Technology and Management (CITM) and has been awarded with 5 Star QS rating for Teaching, Facilities and Social Responsibility). What is more, the MRIIRS is an entity of Manav Rachna Educational Institutions whose foundation was laid by Founder Visionary Dr. O.P Bhalla, a philanthropist and time-transcending educationist.

Advancells, MRIIRS sign agreement to promote research in Healthcare and Biotechnology spheres

Furthermore, MRIIRS is a visible symbol of knowledge providing high quality education in various genres. It is also a Founder Member of the prestigious “College Board’s Indian Global Higher Education Alliance.” MRIIRS offers AICTE approved courses and has been ranked among the Top Educational Institutions of the country in the prestigious ‘India Rankings 2019’ by NIRF, Ministry of Human Resource Development, Government of India, across two categories: Top Universities (rank band 151-200) and Top Engineering (rank 164).